Nickles, Dorothee
Genentech
4 papers on CoChatORCID 0009-0002-5295-1062
Most cited papers
- Verified
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Mariathasan, S., Turley, S. J., Nickles, D., Castiglioni, A., Yuen, K., Wang, Y., Kadel III, E. E., Koeppen, H., Astarita, J. L., Cubas, R., et al. (2018) · Nature
Cancer Immunotherapy and BiomarkersTGF-β signaling in diseases
Cited by 5,400
- Verified
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Rosenberg, J. E., Hoffman-Censits, J., Powles, T., van der Heijden, M. S., Balar, A. V., Necchi, A., Dawson, N., O'Donnell, P. H., Balmanoukian, A., Loriot, Y., et al. (2016) · The Lancet
Bladder and Urothelial Cancer TreatmentsCancer Immunotherapy and Biomarkers
Cited by 3,669
- Verified
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
McDermott, D. F., Huseni, M. A., Atkins, M. B., Motzer, R. J., Rini, B. I., Escudier, B., Fong, L., Joseph, R. W., Pal, S. K., Reeves, J. A., et al. (2018) · Nature Medicine
Renal cell carcinoma treatmentCancer Immunotherapy and Biomarkers
Cited by 1,260
- Verified
T cell-dependent bispecific therapy enhances innate immune activation and antibody-mediated killing
Besla, R., Penuel, E., Del Rosario, G., Cosino, E., Myrta, S., Dillon, M., Lazar, G. A., Nickles, D., Spiess, C., Yu, S.-F., et al. (2024) · Cancer Immunology Research
Immune Cell Function and InteractionMonoclonal and Polyclonal Antibodies Research
Cited by 13
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free